Healthcare provider profile · identity verified

David Morris, FNPBC

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · MILTON, WV · NPI 1306200035

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show David Morris, FNPBC received $198.81 in general payments during 2025 across 2 reported records.

HEARTFLOW, INC. accounted for 57.6% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$198.81

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
HEARTFLOW, INC.	Unresolved — no canonical attribution shown	$114.45	57.6%	1	2025
Insulet Corporation	Unresolved — no canonical attribution shown	$84.36	42.4%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$198.81	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
FFRct Normalized: ffrct	Device	HEARTFLOW, INC.	$114.45	1	2025
Source payment records 2025-11-07 · HEARTFLOW, INC. · $114.45 · Open Payments source
Omnipod Normalized: omnipod	Device	Insulet Corporation	$84.36	1	2025
Source payment records 2025-02-04 · Insulet Corporation · $84.36 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	358	92
Atorvastatin Calcium	Atorvastatin Calcium	314	79
Omeprazole	Omeprazole	298	89
Levothyroxine Sodium	Levothyroxine Sodium	217	54
Amlodipine Besylate	Amlodipine Besylate	198	61
Metformin Hcl	Metformin Hcl	164	45
Gabapentin	Gabapentin	162	38
Albuterol Sulfate Hfa	Albuterol Sulfate	150	43
Metoprolol Succinate	Metoprolol Succinate	140	43
Simvastatin	Simvastatin	138	42
Fluticasone Propionate	Fluticasone Propionate	137	50
Hydrochlorothiazide	Hydrochlorothiazide	134	33
Losartan Potassium	Losartan Potassium	131	43
Pantoprazole Sodium	Pantoprazole Sodium	128	44
Tramadol Hcl	Tramadol Hcl	127	30
Rosuvastatin Calcium	Rosuvastatin Calcium	125	41
Trazodone Hcl	Trazodone Hcl	123	29
Ozempic	Semaglutide	122	26
Furosemide	Furosemide	114	36
Duloxetine Hcl	Duloxetine Hcl	106	27
Tamsulosin Hcl	Tamsulosin Hcl	99	28
Farxiga	Dapagliflozin Propanediol	97	suppressed
Pravastatin Sodium	Pravastatin Sodium	97	25
Sertraline Hcl	Sertraline Hcl	94	27
Prednisone	Prednisone	92	62
Montelukast Sodium	Montelukast Sodium	91	28
Jardiance	Empagliflozin	87	26
Escitalopram Oxalate	Escitalopram Oxalate	82	27
Meloxicam	Meloxicam	77	35
Metoprolol Tartrate	Metoprolol Tartrate	77	17
Baclofen	Baclofen	74	22
Metformin Hcl Er	Metformin Hcl	73	25
Buspirone Hcl	Buspirone Hcl	69	21
Lorazepam	Lorazepam	68	18
Tizanidine Hcl	Tizanidine Hcl	66	19
Carvedilol	Carvedilol	65	22
Clopidogrel	Clopidogrel Bisulfate	65	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	64	15
Eliquis	Apixaban	62	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	14
Potassium Chloride	Potassium Chloride	57	19
Ropinirole Hcl	Ropinirole Hcl	54	12
Clonazepam	Clonazepam	53	13
Fluoxetine Hcl	Fluoxetine Hcl	53	suppressed
Glipizide Er	Glipizide	53	16
Ibuprofen	Ibuprofen	51	16
Pregabalin	Pregabalin	51	suppressed
Bupropion Xl	Bupropion Hcl	50	12
Ondansetron Odt	Ondansetron	50	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	13
Meclizine Hcl	Meclizine Hcl	49	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	48	14
Atenolol	Atenolol	43	13
Ezetimibe	Ezetimibe	43	16
Amitriptyline Hcl	Amitriptyline Hcl	42	suppressed
Citalopram Hbr	Citalopram Hydrobromide	42	12
Ventolin Hfa	Albuterol Sulfate	42	15
Glimepiride	Glimepiride	41	13
Famotidine	Famotidine	40	15
Celecoxib	Celecoxib	39	13
Donepezil Hcl	Donepezil Hcl	38	11
Mounjaro	Tirzepatide	38	suppressed
Alprazolam	Alprazolam	36	suppressed
Allopurinol	Allopurinol	35	11
Fenofibrate	Fenofibrate	35	suppressed
Synthroid	Levothyroxine Sodium	34	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Myrbetriq	Mirabegron	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	20
Arexvy	Rsvpref3 Antigen/As01e/Pf	29	29
Mirtazapine	Mirtazapine	29	suppressed
Amoxicillin	Amoxicillin	28	26
Dicyclomine Hcl	Dicyclomine Hcl	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	16
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Diclofenac Potassium	Diclofenac Potassium	26	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	26	suppressed
Naproxen	Naproxen	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	20
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	23	suppressed
Cephalexin	Cephalexin	22	16
Fluconazole	Fluconazole	22	13
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Azithromycin	Azithromycin	20	15
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Nystatin	Nystatin	20	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Risperidone	Risperidone	18	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Mupirocin	Mupirocin	16	13
Propranolol Hcl	Propranolol Hcl	16	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Glipizide	Glipizide	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Pro Comfort Alcohol Pads	Alcohol Antiseptic Pads	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Estradiol	Estradiol	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$198.81 · 2 records	HEARTFLOW, INC.	FFRct, Omnipod	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error